{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "", "close" : "", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
marketwire

Trinity Biotech plc to Announce Fourth Quarter and Fiscal 2008 Year-End Financial Results

Conference Call Scheduled for March 10, 2009 at 12:00 pm EASTERN

  • Press Release
  • Source: Trinity Biotech
  • On 8:01 am EST, Friday March 6, 2009

Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2008 on Tuesday, March 10, 2009. The Company has scheduled a conference call for that same day, Tuesday, March 10, 2009, at 12:00pm ET (4:00pm GMT) to discuss the results of the quarter.

Interested parties can access the call by dialing:

�
      USA:               1-877-356-5706
      International:     1-706-679-3820

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=56615

A replay of the call can be accessed until March 13, 2009 by dialing:

�
      USA:               1-800-642-1687
      International:     1-706-645-9291
      Conference ID #:   88797617

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=56615

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website: http://www.trinitybiotech.com.

Contact:



Contact:
Ms. Niamh Long
Trinity Biotech plc
Investor Relations Officer
(353 1) 276 9800
 Joe Diaz, Joe Dorame and Robert Blum
Lytham Partners, LLC
602-889-7900
 

Sponsored Links

Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.